N-Acetyl Glucosamine CAS#: 7512-17-6; ChemWhat Code: 1464309

IdentificationPhysical DataSpectra
Route of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameN-Acetyl Glucosamine
Molecular Structure
CAS Registry Number7512-17-6
EINECS Number231-368-2
MDL NumberMFCD00061615
Synonyms7512-17-6
Marine Sweet
GreenNAG
Bio-NAG
aldehydo-N-acetyl-D-glucosamine
acetyl-glucosamine
N acetylglucosamine
CCRIS 9357
DTXSID3045855
N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide
2-Acetamido-2-deoxyglucose
EINECS 231-368-2
UNII-V956696549
NSC 400525
NSC 524344
2 Acetamido 2 Deoxyglucose
N-((2R,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide
AI3-51898
DTXCID5032369
D-Glucose, 2-(acetylamino)-2-deoxy-
V956696549
NSC-400525
NSC-524344
D-Glucose, 2-acetamido-2-deoxy-
N-ACETYLGLUCOSAMINE (USP-RS)
N-ACETYLGLUCOSAMINE [USP-RS]
MFCD00136044
NCGC00159338-02
NCGC00159338-03
N-acetylglucosamines
N Acetyl D Glucosamine
Glucosamine, N-acetyl-
SCHEMBL19900
MLS006011606
N-ACETYL GLUCOSAMINE D-
2 Acetamido 2 Deoxy D Glucose
CHEMBL4303483
N-ACETYLGLUCOSAMINE [MI]
CHEBI:17411
CHEBI:59640
N-ACETYLGLUCOSAMINE [DSC]
HY-A0132
Tox21_111344
BBL033994
MFCD00061615
N-ACETYLGLUCOSAMINE [WHO-DD]
STK801800
AKOS005622647
DB00141
NCGC00159338-05
BP-13072
DS-18661
SMR002121580
CAS-7512-17-6
CS-0017447
S6257
A-1200
AB01325684-02
EN300-7414561
GLUCOPYRANOSE, 2-ACETAMIDO-2-DEOXY-, D-
N-Acetyl-D-glucosamine-Agarose, saline suspension
BRD-K80653534-001-01-7
Q32030210
1186B229-E28C-4CF9-8146-EC06A584F821
GLUCOSAMINE SULFATE POTASSIUM CHLORIDE IMPURITY A [ EP IMPURITY]
27555-50-6
Molecular FormulaC8H15NO6
Molecular Weight221.21
InChIInChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6+,7+,8+/m0/s1
InChI KeyMBLBDJOUHNCFQT-LXGUWJNJSA-N
Isomeric SMILESCC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O

Physical Data

AppearanceWhite powder
Melting Point, °C Solvent (Melting Point)
218
186 – 190ethanol, diethyl ether
197
205 – 207H2O
205
Description (Association (MCS))Temperature (Association (MCS)), °CPartner (Association (MCS))
Association with compound25H2O

Spectra

Description (NMR Spectroscopy)Nucleus (NMR Spectroscopy)Solvents (NMR Spectroscopy)
Chemical shifts13CD2O
Spin-lattice relaxation time (T1)
Spin-spin relaxation time (T2)
NMR

Route of Synthesis (ROS)

Route of Synthesis (ROS) of N-Acetyl-D-glucosamine CAS 7512-17-6
Route of Synthesis (ROS) of N-Acetyl-D-glucosamine CAS 7512-17-6
ConditionsYield
With Biolacta N5 In N,N-dimethylhexanamide at 30℃; pH=5; aq. buffer; Enzymatic reaction; regioselective reaction;

Experimental Procedure
4.5. General procedure for transglycosylation reactions using glycoconjugates
General procedure: A solution of 51.2 mg (0.17 M) p-nitrophenyl-β-d-galactopyranoside (donor) and 188 mg (0.85 M) of N-acetylglucosamine (acceptor) in 1 mL of green solvent (2 M)-buffer mixture was pre-equilibrated to 30 °C. Afterwards, 155 μmol/min (U) of β-galactosidase were added to the reaction mixture. Reaction was monitored by HPLC UV-vis and final products analysed by HPLC with an evaporative light scattering detector (ELSD). The reaction was stopped by heating the sample at 100 °C for 5 min.Isolation of disaccharides was done by carbon/Celite (50% m/m), chromatography, the column was eluted with milliQ water and ethanol gradient (from 5% to 15% v/v). [21] and [26] The structures of the disaccharides (Gal-β(1→4)GlcNAc and Gal-β(1→6)GlcNAc) were assigned by 1H and 13C NMR (D2O, 700 MHz), spectra were identical to previous references. [21], [26] and [27]In order to determine the effect of non-proteic substances present in Biolacta preparation in the reaction yield, transglycosylation reactions were carried out using semipurified (lyophilized) enzyme. The best performing solvents were chosen in view of the previous results, using crude extracts and setting the reactions with semipurified enzymes. The transglycosylation conditions were the same mentioned above and the reaction was monitored using HPLC-ELSD.For functionalized disaccharides the same protocol previously described was used, and different glycoconjugates as acceptors were added. A solution of 51.2 mg (0.17 M) pNP-β-Gal (donor) and the different monosaccharides functionalized 1 and 2 (0.51 M).
86%
With triethyl phosphate; sodium acetate; β-galactosidase In water at 30℃; galactosylation; Enzymatic reaction;

Safety and Hazards

GHS Hazard StatementsNot Classified

Source: European Chemicals Agency (ECHA)
License Note: Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: “Source: European Chemicals Agency, http://echa.europa.eu/”. Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.
License URL: https://echa.europa.eu/web/guest/legal-notice
Record Name: (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate
URL: https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/213446
Description: The information provided here is aggregated from the “Notified classification and labelling” from ECHA’s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database


Other Data

StorageStored at room temperature for long time; Sealed and keep away from light.
Use Pattern
N-Acetylglucosamine is a versatile ingredient widely used in pharmaceuticals, cosmetics, health supplements, and biomedical materials. Its primary sources include animal extraction and microbial fermentation.
In the pharmaceutical field, it helps improve joint health, promotes cartilage matrix synthesis by chondrocytes, enhances cartilage repair, and alleviates joint pain. As a derivative of glucosamine, it supports skin health and tissue repair.
In cosmetics, it stimulates the synthesis of hyaluronic acid (HA), enhancing skin hydration. It also repairs the skin barrier, reducing redness and sensitivity, while accelerating epidermal cell renewal and promoting wound healing.

Buy Reagent

No reagent supplier? Send quick inquiry to ChemWhat
Want to be listed here as a reagent supplier? (Paid service) Click here to contact ChemWhat

Approved Manufacturers

Want to be listed as an approved manufacturer (Requires approvement)? Please download and fill out this form and send back to approved-manufacturers@chemwhat.com

Contact Us for Other Help

Contact us for other information or services Click here to contact ChemWhat